EUVIMEDEUVIMED entdecken
Open Access

Interpretation of Antimicrobial Susceptibility Testing Using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) Breakpoints: Analysis of Agreement

Priyanka Gaur, Vivek Hada, Rama S Rath, Aroop Mohanty, Parul Singh, Atul Rukadikar

Cureus · 31.03.2023

DOI: 10.7759/cureus.36977 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 31.03.2023. Verfasst von Priyanka Gaur und 5 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology, All India Institute of Medical Sciences, Gorakhpur, Gorakhpur, IND. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Breakpoints provided by European Committee on Antimicrobial Susceptibility Testing (EUCAST) are now being used in many countries. This study was planned to ascertain the agreement in antimicrobial susceptibility using the Clinical and Laboratory Standards Institute (CLSI) and EUCAST breakpoints during the Kirby-Bauer disk diffusion method. METHODS: This was a prospective observational study. Clinical isolates belonging to the family Enterobacteriaceae recovered between January and December, 2022, were included in the analysis. The diameter of the zone of inhibition of the 14 antimicrobials (viz. amoxicillin/clavulanic acid, cefazolin, ceftriaxone, cefuroxime, cefixime, aztreonam, meropenem, gentamicin, amikacin, ciprofloxacin, levofloxacin, norfloxacin, trimethoprim/sulfamethoxazole and fosfomycin) was analysed. Antimicrobial susceptibility was interpreted using CLSI 2022 and EUCAST 2022 guidelines.

Results

Susceptibility data from a total of 356 isolates showed a slight increase in the percentage of resistant isolates with most of the drugs using EUCAST guidelines. The level of agreement varied from almost perfect to slight. For two drugs, i.e., fosfomycin and cefazolin, the agreement was least among the drug analysed (kappa (κ) value < 0.5, p < 0.001). For Ceftriaxone and Aztreonam, with EUCAST, susceptible (S) isolates would have been categorised in the newly redefined "I" category. It would have indicated the use of higher dosages of drugs.

Conclusion

Change in the breakpoints impacts the interpretation of the susceptibility. It can also lead to a change in the dosage of the drug used for treatment. Therefore, there is an urgent need to see the impact of recent modifications "I" category of EUCAST on the clinical outcome and usage of antimicrobials.

Schlagwörter

Stichwörter der Autor:innen

amrantimicrobial susceptibility testingcefazolinclsidisk diffusioneucastfosfomycin

Autor:innen und Institutionen

  • Microbiology, All India Institute of Medical Sciences, Gorakhpur, Gorakhpur, IND.
  • Community Medicine, All India Institute of Medical Sciences, Gorakhpur, Gorakhpur, IND.

Zitieren

APA

Gaur, P., Hada, V., Rath, R. S., Mohanty, A., Singh, P., & Rukadikar, A. (2023). Interpretation of Antimicrobial Susceptibility Testing Using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) Breakpoints: Analysis of Agreement. Cureus. https://doi.org/10.7759/cureus.36977

Vancouver

Gaur P, Hada V, Rath RS, Mohanty A, Singh P, Rukadikar A. Interpretation of Antimicrobial Susceptibility Testing Using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) Breakpoints: Analysis of Agreement. Cureus. 2023. doi:10.7759/cureus.36977

BibTeX
@article{Gaur2023,
  author = {Gaur, Priyanka and Hada, Vivek and Rath, Rama S and Mohanty, Aroop and Singh, Parul and Rukadikar, Atul},
  title = {Interpretation of Antimicrobial Susceptibility Testing Using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) Breakpoints: Analysis of Agreement},
  journal = {Cureus},
  year = {2023},
  doi = {10.7759/cureus.36977}
}
Kostenlos starten →